Skip to content
DataLookout
Menu

NECTAR IVNCT05369065

Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities

StatusActive, Not Recruiting
PhasePhase 1
Primary completion (estimated)

At risk: Primary completion moved at least 2 years 4 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jan 2025 to Jun 2027 Show 5 more changesShow less
    • Eligibility criteria expanded, about 71 words
    • Enrollment closed, study ongoing
    • Study completion pushed from Jan 2029 to Jan 2030
    • Secondary endpoints: details revised at 4 of 7 entries
    • Site details revised at 3 of 3 sites
  2. Notable Lead sponsor: [Redacted] to Neurotronic, Inc.v2 Show 6 more changesShow less
    • Trial status: Withheld to Recruiting
    • Primary completion date: Jan 2025
    • Study completion date: Jan 2029
    • Start date: Jan 27, 2022
    • Collaborators expanded, about 2 words
    • Study title expanded, about 1 word
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Incidence of serious device- and procedure-related complications at 30 days post procedure.
Timeframe: 30 Days
Device success
Timeframe: Procedure Day

Secondary (7)

Glycemic Control - HbA1c
Glycemic Control - fasting glucose
Hypertension Control - ABPM
Hypertension Control - Office Blood Pressure
Procedure success
Show 2 moreShow less
Change of anti-hyperglycemic medications
Change of anti-hypertensive medications

Arms and interventions

Ablation TreatmentExperimental

The participants randomized to this arm will receive Neurotronic ablation treatment.

Sham TreatmentSham comparator

The participants randomized to this arm will have a sham procedure (angiography only)

Single Arm non-Randomized TreatmentExperimental

The participants treated in this arm will receive the Neurotronic ablation treatment

Combination products: Ablation Treatment, Single Arm non-Randomized Ablation Treatment

Diagnostic tests: Arterial Angiography Only

Sites

3 sites in 1 country